Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Prototype Mini Nicotine Lozenge vs Nicorette Minis
NCT03543137Phase 1Completed
- Sponsor
- GSK
- Start
- Jun 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nicotine in Tobacco Use Disorder (TUD) (2 arms), sponsored by GSK. Primary endpoints: Area Under the Plasma Concentration Versus Time Curve From Time Zero to Time t, Area Under the Plasma Concentration Versus Time Curve From Time Zero to Infinity and 1 more. Started Jun 2018; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03543137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03543137.